Home » Topics » BioWorld Science

BioWorld Science
RSS

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Potential drug screening invention available for licensing

Nov. 27, 1996

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Nov. 27, 1996

Initial human safety studies completed for CoCensys' stroke drug

Nov. 27, 1996

Water-soluble fiber introduced in first market for high cholesterol

Nov. 27, 1996

XOMA receives U.S. patents covering BPI-related products

Nov. 27, 1996

Ebselen on track for NDA filing in Japan

Nov. 27, 1996

Agreement reached for atorvastatin development in Japan

Nov. 27, 1996

Clinical results reported for rhIGF-I in ALS patients

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...